Evercore ISI Group Maintains Outperform on Abbott Laboratories, Lowers Price Target to $112

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $120 to $112.